SBH // Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
ANR <GO> NYSE RQD COCKPIT → CIK 0001368458 ↗ Consumer Discretionary • Other Specialty Stores
$18.23 ▲ +0.82
(+4.71%)
MKT CAP: $1.71B • VOL: 1.35M
52W L $12 52W H $18
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$15
MEDIAN
$20
MEAN
$21
HIGH
$25
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE SBH TAPE
SBH // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $22.06 | $20.96 | 2025-02-14 | $16.59 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $22.97 | $21.51 | 2025-02-06 | $17.14 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $20.78 | $20.05 | 2025-01-29 | $17.50 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $18.59 | — | 2025-01-17 | $17.87 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $16.04 | $17.32 | 2025-01-09 | $16.22 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $21.69 | $18.96 | 2024-12-18 | $15.86 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $17.68 | $18.41 | 2024-12-04 | $16.95 | -4.3% | 48% | C |